These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 4024070)

  • 1. Cardiovascular and respiratory effects of antiarrhythmic drugs on conscious beagles.
    Hashimoto K; Shibuya T; Imai S
    Tohoku J Exp Med; 1985 Apr; 145(4):359-67. PubMed ID: 4024070
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hemodynamic effects of antiarrhythmic drugs.
    Block PJ; Winkle RA
    Am J Cardiol; 1983 Sep; 52(6):14C-23C. PubMed ID: 6414278
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Electrophysiologic study of antiarrhythmic agents in man].
    Puech P
    Arch Inst Cardiol Mex; 1977; 47(2):233-47. PubMed ID: 901058
    [No Abstract]   [Full Text] [Related]  

  • 4. Antiarrhythmic agents and their use in therapy.
    Dreifus LS; Morganroth J
    Pharmacol Ther; 1980; 9(1):75-106. PubMed ID: 6994141
    [No Abstract]   [Full Text] [Related]  

  • 5. Intropic effects of several antiarrhythmic drugs.
    Ferro G; Chiariello M; Tari MG; Vigorito C; Ungaro B; Condorelli M
    Jpn Heart J; 1983 May; 24(3):377-90. PubMed ID: 6876382
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effective plasma concentrations of antiarrhythmic drugs against sustained halothane-adrenaline arrhythmia in dogs.
    Shibuya T; Hashimoto K; Imai S
    J Cardiovasc Pharmacol; 1983; 5(4):538-45. PubMed ID: 6193348
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Toxic and hemodynamic effects of aprindine in the dog. Comparison with other anti-arrhythmia agents].
    Lisin N; Carlier J
    Acta Cardiol; 1974; Suppl 18():117-30. PubMed ID: 4547497
    [No Abstract]   [Full Text] [Related]  

  • 8. Observations on the effects of selected antiarrhythmic drugs on mammalian cardiac purkinje fibers with two levels of steady-state potential: influences of lidocaine, phenytoin, propranolol, disopyramide and procainamide on repolarization, action potential shape and conduction.
    Arnsdorf MF; Mehlman DJ
    J Pharmacol Exp Ther; 1978 Dec; 207(3):983-91. PubMed ID: 731444
    [No Abstract]   [Full Text] [Related]  

  • 9. Cardiovascular drugs. I: Antidysrhythmic drugs.
    Wettrell G; Andersson KE
    Ther Drug Monit; 1986; 8(1):59-77. PubMed ID: 3083538
    [No Abstract]   [Full Text] [Related]  

  • 10. Human organic cation transporter 3 mediates the transport of antiarrhythmic drugs.
    Hasannejad H; Takeda M; Narikawa S; Huang XL; Enomoto A; Taki K; Niwa T; Jung SH; Onozato ML; Tojo A; Endou H
    Eur J Pharmacol; 2004 Sep; 499(1-2):45-51. PubMed ID: 15363950
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative mechanisms of action of antiarrhythmic drugs.
    Singh BN; Hauswirth O
    Am Heart J; 1974 Mar; 87(3):367-82. PubMed ID: 4149610
    [No Abstract]   [Full Text] [Related]  

  • 12. Effects of lidocaine, disopyramide and verapamil on the in vivo triggered ventricular arrhythmia in digitalized canine heart.
    Akiyama K; Hashimoto K
    Jpn J Pharmacol; 1990 Aug; 53(4):419-26. PubMed ID: 2214367
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Electropharmacology of antiarrhythmic drugs.
    Rosen MR; Wit AL
    Am Heart J; 1983 Oct; 106(4 Pt 2):829-39. PubMed ID: 6412533
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rational basis of antiarrhythmic therapy: clinical pharmacology of commonly used antiarrhythmic drugs.
    Singh BN
    Angiology; 1978 Mar; 29(3):206-42. PubMed ID: 347988
    [No Abstract]   [Full Text] [Related]  

  • 15. Haemodynamic effects of class I antiarrhythmic agents.
    Legrand V; Collignon P
    Drugs; 1985; 29 Suppl 4():54-7. PubMed ID: 3924551
    [TBL] [Abstract][Full Text] [Related]  

  • 16. General pharmacological studies on N-(2,6-dimethylphenyl)-8-pyrrolizidineacetamide hydrochloride hemihydrate. 3rd communication: effect on cardiovascular system.
    Aisaka K; Hidaka T; Hattori Y; Inomata N; Ishihara T; Satoh F
    Arzneimittelforschung; 1988 Oct; 38(10):1417-25. PubMed ID: 3196382
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Responses to ligation of a coronary artery in conscious rats and the actions of antiarrhythmics.
    Johnston KM; MacLeod BA; Walker MJ
    Can J Physiol Pharmacol; 1983 Nov; 61(11):1340-53. PubMed ID: 6661688
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of disopyramide on SA nodal pacemaker activity and contractility in the isolated blood-perfused atrium of the dog.
    Chiba S; Kobayashi M; Furukawa Y
    Eur J Pharmacol; 1979 Jul; 57(1):13-9. PubMed ID: 477737
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Canine-effective plasma concentrations of antiarrhythmic drugs on the two-stage coronary ligation arrhythmia.
    Hashimoto K; Satoh H; Shibuya T; Imai S
    J Pharmacol Exp Ther; 1982 Dec; 223(3):801-10. PubMed ID: 7143241
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cardiovascular effects of a newer antiarrhythmic agent, disopyramide phosphate.
    Mathur PP
    Am Heart J; 1972 Dec; 84(6):764-70. PubMed ID: 4150336
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.